Parcae Capital
Got an idea or business that is in need of funding? Why not source this through crowdfunding!
Strike up the conversation and contact us on determining the options available to you and your business!
CLICK HERE and tell us a little bit about your business.
Parcae Capital are experts in helping you deliver the messaging to secure the proper broadcasting to the right crowdfunding sources.
The three top methods of crowdfunding are Equity, Donation and Debt . Each of the three crowdfunding options come with benefits and with so many outlets from micro angels to IndieGoGo, Kickstarter, CrowdCube, CrowdWise and many new sources popping up daily it is hard to navigate the right path and type of crowdfunding best for your business to ensure your able to reach your targeted start up funding goals.
With decades of experience in business architecture and strategic planning Frank Magliochetti and the team at Parcae Capital are trusted leaders for you and your business to turn to to guide you in this decision making process.
North Andover businessman Frank Magliochetti is managing partner at Parcae Capital Corporation.
Parcae Capital provides financial restructuring and interim management to emerging businesses.
Parcae Capital offers personalized investment banking services for emerging growth companies. They specialize in finding companies which have leading edge technology, services or intellectual property in the healthcare, media and alternative energy space. Parcae Capital assist both public and private companies in preparing to raise private and public capital for all phases of growth. Parcae Capital also offers comprehensive assistance in mergers, acquisitions and related services. Their work out group specializes in business restructuring and recapitalization.
Frank is also the Chairman at Rehab Medical Holdings Incorporated an orthopedic medical device holding company.
In the past, Frank has held positions as Chairman and CEO at Chartwell Diversified Services, SVP at Sandoz, VP of North American Operations for Haemonics and CEO for Worldwide Cardiovascular Division for Kontron Medical.
